Kevin Schwartz

MD, MSc, FRCPC, DTM&H

Investigator, Li Ka Shing Knowledge Institute

Biography

Kevin Schwartz is an infectious disease physician. He is the division head for infectious diseases at St. Joseph’s Health Centre in Toronto and co-medical director for antimicrobial stewardship at Unity Health Toronto. He is an academic infection control and antimicrobial stewardship physician at Public Health Ontario, an assistant professor at the Dalla Lana School of Public Health at the University of Toronto, and an adjunct scientist at ICES.

His clinical area of interest is adult and pediatric infectious diseases and tropical medicine. His research interests include vaccine preventable diseases and antimicrobial stewardship with a particular focus on improving community antibiotic use to slow the emergence of drug resistant infections.

Recent Publications

  1. Ivankovic, M, Schwartz, KL. [Not Available]. CMAJ. 2025;197 (3):E81-E82. doi: 10.1503/cmaj.240246-f. PubMed PMID:39870405 PubMed Central PMC11772001.
  2. Langford, BJ, Schwartz, KL. Audit and feedback to improve antibiotic prescribing in primary care-the time is now. BMJ Qual Saf. 2025; :. doi: 10.1136/bmjqs-2024-018081. PubMed PMID:39798992 .
  3. Langford, BJ, Brown, KA, Lau, C, Calzavara, A, Krueger, C, Leung, V et al.. Evaluating Harms Associated with Prolonged Antibiotic Duration of Therapy in Community Dwelling Older Adults: A Cohort Study using Instrumental Variable Analysis. Clin Infect Dis. 2024; :. doi: 10.1093/cid/ciae629. PubMed PMID:39786490 .
  4. Tu, M, Shi, ZH, Leung, V, Brown, KA, Schwartz, KL, Daneman, N et al.. Hospital antimicrobial stewardship funding and resourcing impact on broad-spectrum antibiotic use: a cross-sectional study. Antimicrob Steward Healthc Epidemiol. 2024;4 (1):e223. doi: 10.1017/ash.2024.461. PubMed PMID:39758877 PubMed Central PMC11696587.
  5. Grewal, R, Nguyen, L, Buchan, SA, Wilson, SE, Nasreen, S, Austin, PC et al.. Author Correction: Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes. Nat Commun. 2024;15 (1):10709. doi: 10.1038/s41467-024-55350-3. PubMed PMID:39706844 PubMed Central PMC11662008.
  6. Blagojevic, C, Brown, KA, Diong, C, Fridman, DJ, Johnstone, J, Langford, BJ et al.. Long-term Risk of Infection Among Patients Colonized With Antimicrobial-Resistant Pathogens: A Population-wide Cohort Study. Open Forum Infect Dis. 2024;11 (12):ofae712. doi: 10.1093/ofid/ofae712. PubMed PMID:39703788 PubMed Central PMC11656336.
  7. Leung, V, Ashiru-Oredope, D, Hicks, L, Kabbani, S, Aloosh, M, Armstrong, IE et al.. Leveraging local public health to advance antimicrobial stewardship (AMS) implementation and mitigate antimicrobial resistance (AMR): a scoping review. JAC Antimicrob Resist. 2024;6 (6):dlae187. doi: 10.1093/jacamr/dlae187. PubMed PMID:39698503 PubMed Central PMC11651725.
  8. Wang, Y, Swayze, S, Brown, KA, MacFadden, DR, Lee, SM, Schwartz, KL et al.. Prevalence and Predictors of Concomitant Bacterial Infections in Patients With Respiratory Viruses in Ontario: A Cohort Study. Open Forum Infect Dis. 2024;11 (12):ofae701. doi: 10.1093/ofid/ofae701. PubMed PMID:39691293 PubMed Central PMC11651150.
  9. Xu, AXT, Brown, K, Schwartz, KL, Aghlmandi, S, Alderson, S, Brehaut, J et al.. Audit and Feedback Interventions for Antibiotic Prescribing in Primary Care: A Systematic Review and Meta-analysis. Clin Infect Dis. 2024; :. doi: 10.1093/cid/ciae604. PubMed PMID:39657007 .
  10. Piché-Renaud, PP, Drover, SSM, Austin, PC, Morris, SK, Buchan, SA, Nasreen, S et al.. COVID-19 vaccine effectiveness against severe omicron-related outcomes in children aged 5 to 11 years in Ontario: A Canadian immunization research network (CIRN) study. Vaccine. 2025;44 :126539. doi: 10.1016/j.vaccine.2024.126539. PubMed PMID:39617675 .
Search PubMed

Affiliations & Other Activities

  • Public Health Ontario
  • Adjunct Scientist ICES
  • Assistant Professor, Dalla Lana School of Public Health, University of Toronto